Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-3572

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-3572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3572 4)

This text provides information about Lansoprazole 30mg capsules by Pharmaceuticals, Inc. It includes details like the NDC number, lot number, expiration date, dosage, and storage instructions. The text also warns to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F.*

FDA Label Image

Figure-1.jpg (Figure 1)

This is a description of the mean severity of daytime heartburn by study day for evaluable patients. The severity is categorized on a scale of 0 to 3 (0 = None, 1 = Mild, 2 = Moderate, 3 = Severe). The data compares the effects of placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The information is presented over a period of days from the start of treatment.*

FDA Label Image

Figure-2.jpg (Figure 2)

This text provides information on the mean severity of night heartburn for evaluable patients over time, categorized from severe to none. The data compares the efficacy of a placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD in managing night heartburn. The study shows the progression of heartburn severity over different days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.